l carnitine and tma γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO TMAO Is Both a Biomarker
TMAO Is Both a Biomarker and a Renal Toxin Circulation Research Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target Gut microbiota metabolism of l carnitine and cardiovascular risk ScienceDirect Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PMC
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



